Vaccinations versus Lockdowns to Prevent COVID-19 Mortality

被引:11
作者
Arbel, Ronen [1 ,2 ]
Pliskin, Joseph [3 ,4 ]
机构
[1] Sapir Coll, Maximizing Hlth Outcomes Res Lab, IL-7956000 Sderot, Israel
[2] Clalit Hlth Serv, Community Med Serv Div, IL-6209804 Tel Aviv, Israel
[3] Ben Gurion Univ Negev, Dept Hlth Policy & Management, Ind Engn & Management, IL-84105 Beer Sheva, Israel
[4] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 43222 USA
关键词
COVID-19; vaccinations; mortality; lockdown;
D O I
10.3390/vaccines10081347
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Measures employed to combat COVID-19 included public lockdowns and vaccination campaigns. Israel's extensive public health system produced data demonstrating the real-world results of these measures. Our objective was to evaluate the health and economic outcomes of the measures to cope with COVID-19. Publicly available datasets from the Israeli Ministry of Health were used to model the parameters of the pandemic in Israel. The Oxford COVID-19 Government Response Tracker was used for quantitative data on government policies. Data on the Israeli economy were taken from the Central Bureau of Statistics. Our models demonstrate that the first lockdown prevented 1022 COVID-19 deaths at the cost of 36.4-38.6 billion NIS. The second lockdown prevented 1970 COVID-19 deaths and cost 18-21 billion NIS. These lifesaving effects were observed with a time lag from the declaration of lockdown. The primary vaccination campaign cost 1 billion NIS and prevented 4750 COVID-19 deaths. The first vaccination booster campaign prevented 650 COVID-19 deaths and cost 51.1 million NIS. Therefore, the cost per prevented COVID-19 death is 10-36 million NIS with a national lockdown versus 210,000 NIS in the primary vaccination campaign and 79,000 NIS in the first booster campaign. In conclusion, both lockdowns and vaccination campaigns effectively lower COVID-19 deaths, but the cost to avoid one COVID-19 death with effective vaccination is 50-466 times lower than with a lockdown.
引用
收藏
页数:7
相关论文
共 25 条
[1]  
[Anonymous], COVID 19 DASHBOARD C
[2]  
[Anonymous], WHO, Patent No. 158818
[3]   Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years [J].
Arbel, Ronen ;
Sergienko, Ruslan ;
Friger, Michael ;
Peretz, Alon ;
Beckenstein, Tanya ;
Yaron, Shlomit ;
Netzer, Doron ;
Hammerman, Ariel .
NATURE MEDICINE, 2022, 28 (07) :1486-+
[4]  
Arbel R, 2022, NEW ENGL J MED, V386, P1000, DOI 10.1056/NEJMc2120044
[5]   How many lives do COVID vaccines save? Evidence from Israel [J].
Arbel, Ronen ;
Moore, Candace Makeda ;
Sergienko, Ruslan ;
Pliskin, Joseph .
AMERICAN JOURNAL OF INFECTION CONTROL, 2022, 50 (03) :258-261
[6]   BNT162b2 Vaccine Booster and Mortality Due to Covid-19 [J].
Arbel, Ronen ;
Hammerman, Ariel ;
Sergienko, Ruslan ;
Friger, Michael ;
Peretz, Alon ;
Netzer, Doron ;
Yaron, Shlomit .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (26) :2413-2420
[7]  
Bank of Israel, EC STABILITY REPORT
[8]  
Blavatnik School of Government, 2020, CORONAVIRUS GOVT RES
[9]   A literature review of the economics of COVID-19 [J].
Brodeur, Abel ;
Gray, David ;
Islam, Anik ;
Bhuiyan, Suraiya .
JOURNAL OF ECONOMIC SURVEYS, 2021, 35 (04) :1007-1044
[10]   WHAT THE LATEST OMICRON SUBVARIANTS MEAN FOR THE PANDEMIC [J].
Callaway, Ewen .
NATURE, 2022, 606 (7916) :848-849